z-logo
open-access-imgOpen Access
Country-based report: the safety of omalizumab treatment in pregnant patients with asthma
Author(s) -
Bilun Gemicioğlu,
Arzu Didem Yalçın,
Yavuz Havlucu,
Gül Karakaya,
Levent Özdemır,
Metin Keren,
Sevim Bavbek,
Dane Ediger,
İpek Kıvılcım Oğuzülgen,
Zeynep Ferhan Özşeker,
A. Yorgancioglu
Publication year - 2021
Publication title -
turkish journal of medical sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.277
H-Index - 27
eISSN - 1303-6165
pISSN - 1300-0144
DOI - 10.3906/sag-2101-341
Subject(s) - medicine , omalizumab , asthma , intensive care medicine , immunology , immunoglobulin e , antibody
We aimed to report outcomes of pregnant patients with asthma under omalizumab treatment and their infants in our country.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here